eHealth Q3 Revenue Falls 60% to $21.3M, Missing Estimates; FY26 Guidance Held
EHTH sits 32% above its 52-week low of $0.454 on elevated volume (3.1× avg).
Summary
Q3 revenue came in at $21.3 million against a $26.42 million consensus from four analysts, a 60% year-over-year decline driven by deliberately slashed variable marketing outside enrollment periods. The quarter produced a $1.57 loss per share. Management reiterated full-year 2026 revenue of $405.0-445.0 million, GAAP net income of $8.0-25.0 million and adjusted EBITDA of $55.0-75.0 million, so the miss did not shake the annual plan. The company is betting the lifetime advisory model pays off: 90-day retention improved for the Q2 Medicare Advantage cohort and Q3 ancillary cross-sell rates nearly doubled year over year. This lands two weeks after the 8-K disclosing a Nasdaq notice that shares traded below $1.00 for 30 consecutive business days, and with the stock at $0.601 the listing clock is the bigger issue than the revenue line.
At the time of this announcement, EHTH was trading at $0.60 on NASDAQ in the Finance sector, with a market capitalization of approximately $20.3M. The 52-week trading range was $0.45 to $5.35. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.